StockData
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. (XENE) stock

XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$37.04−0.52 (-1.38%)

Close on Nov 20, 2026Market cap $3.59BP/E –Yield –

Xenon Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Xenon Pharmaceuticals

Xenon Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Xenon Pharmaceuticals figures

See a number that looks wrong?